Sort
10,766 grants matching “checkpoint inhibitor”
Building the foundations of commensal vaccines
$751,181Michael Andrew Fischbach · Stanford University · R01 · FY2024 · AI
Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids
$750,924Thomas G Boyer · University Of Texas Hlth Science Center · R01 · FY2022 · HD
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
$750,686Sumita Bhaduri-McIntosh · University Of Florida · U01 · FY2024 · CA
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
$750,686Sumita Bhaduri-McIntosh · University Of Florida · U01 · FY2023 · CA
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune Systems
$750,000Richard D Schulick · University Of Colorado Denver · P30 · FY2024 · CA
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2019 · CA
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2020 · CA
Immunological approaches to overcoming therapy resistance in human tumors
$749,999Dario C. Altieri · Wistar Institute · P30 · FY2024 · CA
Project 1 - Clinical Trial
$749,398Andrew R Haas · University Of Pennsylvania · P01 · FY2020 · CA
Project 1 - Clinical Trial
$749,398Andrew R Haas · University Of Pennsylvania · P01 · FY2021 · CA
Project 1 - Clinical Trial
$749,397Andrew R Haas · University Of Pennsylvania · P01 · FY2018 · CA
A Platform Technology to Genetically Reprogram Cancer Cells for Enhanced Immunotherapy
$749,156Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2025 · CA
Molecular, Cellular, and Tissue Characterization Unit
$749,044Joe W. Gray · Oregon Health & Science University · U2C · FY2019 · CA
Radiation-induced translational control of gene expression
$748,682Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic Tumorigenesis
$748,012Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$747,163Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
$746,809Stephen C Mack · St. Jude Children'S Research Hospital · U01 · FY2024 · CA
Radiation-induced translational control of gene expression
$746,706Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Discovering and characterizing the germline mechanisms of cutaneous immune-related adverse events (cirAE)
$746,572Nicole R Leboeuf · Brigham And Women'S Hospital · R01 · FY2025 · AR
Molecular, Cellular, and Tissue Characterization Unit
$746,441Joe W. Gray · Oregon Health & Science University · U2C · FY2021 · CA
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$745,334Andrew Sikora · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · DE
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$745,273Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Three-dimensional Structures Of Biological Macromolecules
$745,223Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping
$745,169Han Zhu · Stanford University · R01 · FY2025 · HL
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
$745,005Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA